Answer questions and earn CME/CNE Laryngeal cancer remains one of the most common
tumors of the respiratory tract. Fortunately, significant advancements have been made over …

The HER3 protein, that belongs to the ErbB/HER receptor tyrosine kinase (RTK) family, is
expressed in several types of tumors. That fact, together with the role of HER3 in promoting …

Epidermal growth factor receptor (EGFR) overexpression is common in head and neck
squamous cell carcinoma. Targeted therapy specifically directed towards EGFR has been …

Overexpression and increased signaling from the epidermal growth factor receptor (EGFR)
often changes oral squamous cell carcinoma (OSCC) and thus EGFR is frequently targeted …

Immune checkpoint blockade (ICB) therapy has revolutionized head and neck squamous
cell carcinoma (HNSCC) treatment, but< 20% of patients achieve durable responses …

Oral cancer is a common malignant tumor of the head and neck, and surgery combined with
radiotherapy and chemotherapy is the primary treatment modality. However, a positive …

Cetuximab, the FDA-approved anti-EGFR antibody for head and neck squamous cell
carcinoma (HNSCC), has displayed limited efficacy due to the emergence of intrinsic and …

Oral cancer is a highly aggressive tumor with invasive properties that can lead to metastasis
and high mortality rates. Conventional treatment strategies, such as surgery, chemotherapy …

Head and neck squamous cell carcinoma (HNSCC) is the sixth most incident cancer
worldwide. More than half of HNSCC patients experience locoregional or distant relapse to …

In the era of precision medicine, it has been increasingly recognized that individuals with a
certain disease are complex and different from each other. Due to the underestimation of the …